Axsome Therapeutics (NASDAQ:AXSM) Research Coverage Started at Needham & Company LLC
Needham & Company LLC started coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report released on Monday, MarketBeat.com reports. The firm issued a buy rating and a $130.00 price objective on the stock. Other analysts have also recently issued reports about the stock. Mizuho restated a buy rating and set […]
More Stories
Radius Recycling (NASDAQ:RDUS) Issues Quarterly Earnings Results
Radius Recycling (NASDAQ:RDUS – Get Free Report) released its earnings results on Tuesday. The basic materials company reported ($1.33) earnings...
RPM International (NYSE:RPM) Releases Earnings Results, Beats Expectations By $0.05 EPS
RPM International (NYSE:RPM – Get Free Report) announced its quarterly earnings results on Tuesday. The specialty chemicals company reported $1.39...
StockNews.com Initiates Coverage on Cumulus Media (NASDAQ:CMLS)
StockNews.com began coverage on shares of Cumulus Media (NASDAQ:CMLS – Free Report) in a research report report published on Wednesday....
Insider Selling: SentinelOne, Inc. (NYSE:S) CEO Sells 60,864 Shares of Stock
SentinelOne, Inc. (NYSE:S – Get Free Report) CEO Tomer Weingarten sold 60,864 shares of the stock in a transaction that...
BlackRock (NYSE:BLK) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of BlackRock (NYSE:BLK – Free Report) in a research report report published on Wednesday morning....
Summit Materials (NYSE:SUM) Downgraded to Hold Rating by Stephens
Summit Materials (NYSE:SUM – Get Free Report) was downgraded by analysts at Stephens from a “strong-buy” rating to a “hold”...